GeminIQ Website Logo

Viewing PBH free

Subscribe for full history, 90+ metrics, screener, watchlist...

Prestige Consumer Healthcare Inc.

PBH

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
89646211914098515234466460
Accounts Receivable Net Current
187192190199168194167164172177174158
Inventory Net
190159164159153148152156152139149161
Prepaid Expense And Other Assets Current
3017172019889111378
Assets Current
497431433497481448377381369375394388
Property Plant And Equipment Net
117122128737475747575777071
Operating Lease Right Of Use Asset
26282425272830910111112
Finance Lease Right Of Use Asset
-2223232425501223
Goodwill
651581581528528527527529528528528527
Intangible Assets Net Excluding Goodwill
3,2432,3002,3022,2912,2952,2952,3112,3172,3182,3212,3292,328
Other Assets Noncurrent
13114333676664
Assets
4,5693,4943,4953,4423,4323,4023,3293,3173,3083,3183,3403,333
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
372343422219203140393944
Interest And Dividends Payable Current
181615161516151615161516
Operating Lease Liability Current
776666634567
Finance Lease Liability Current
-33332101123
Liabilities Current
154121140135110107103107114117127130
Long Term Debt
-9941,0349939939929921,0521,0911,1261,1991,263
Long Term Debt Noncurrent
---------1,126--
Deferred Income Tax Liabilities Net
449447449445427420413415409404397388
Operating Lease Liability Noncurrent
1921182021232477867
Finance Lease Liability Noncurrent
-1819192021400000
Other Liabilities Noncurrent
666555555999
Liabilities
2,6521,6071,6651,6171,5761,5671,5411,5851,6271,6631,7391,797
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
111111111111
Additional Paid In Capital
613609605603600593588577573567556552
Treasury Stock Common Value
-442-439-439-392-316-277-266-263-252-220-220-220
Accumulated Other Comprehensive Income Loss Net Of…
-30-28-30-32-32-38-40-27-31-34-29-36
Retained Earnings Accumulated Deficit
1,7751,7461,6921,6451,6031,5561,5061,4451,3901,3411,2921,239
Stockholders Equity
1,9171,8881,8291,8251,8551,8351,7881,7321,6811,6551,6011,536
Liabilities And Stockholders Equity
4,5693,4943,4953,4423,4323,4023,3293,3173,3083,3183,3403,333
Allowance For Doubtful Accounts Receivable Current
201821191416171819161922
Stockholders Equity Numbe…
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
555555555555
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
250250250250250250250250250250250250
Common Stock Shares Issued
565656565656565656565555
Treasury Stock Common Shares
999877666666

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2027------------
20260.64%-6.86%-7.96%-2.95%2.40%7.24%5.72%-9.66%-10.08%2.72%7.60%9.34%
202511.67%6.70%9.28%5.84%-2.05%-4.26%-2.98%-2.59%-7.80%-1.87%-7.33%-11.94%
2024----1.44%4.68%0.61%1.93%5.47%2.43%-1.53%2.80%6.12%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
3.23
3.57
3.11
3.70
4.38
4.20
3.68
3.56
3.23
3.20
3.09
2.99
Quick Ratio
1.80
2.12
1.81
2.36
2.81
2.74
2.13
2.01
1.80
1.91
1.87
1.68
Working Capital
343.01M
310.56M
293.87M
362.81M
370.85M
341.71M
274.62M
273.80M
254.63M
258.00M
266.35M
258.49M
Leverage & Debt
Debt to Equity
1.38
0.85
0.91
0.89
0.85
0.85
0.86
0.92
0.97
1.00
1.09
1.17
Interest Coverage TTM
9.03
7.31
7.74
7.82
7.53
7.07
6.34
5.68
5.26
5.10
-0.29
-0.28
Debt Ratio
0.58
0.46
0.48
0.47
0.46
0.46
0.46
0.48
0.49
0.50
0.52
0.54
Efficiency & Turnover
Asset Turnover TTM
0.28
0.32
0.32
0.33
0.33
0.34
0.34
0.33
0.33
0.34
0.32
0.32
Days Sales Outstanding TTM
58.76
64.74
59.16
59.58
55.41
59.52
55.74
52.91
54.04
55.75
53.32
49.30
Receivables Turnover TTM
6.21
5.64
6.17
6.13
6.59
6.13
6.55
6.90
6.75
6.55
6.85
7.40
Per Share Metrics
Diluted EPS TTM
3.61
3.91
3.88
4.08
4.27
4.29
4.28
4.12
4.08
4.17
-1.61
-1.63
Free Cash Flow Per Share TTM
6.61
3.86
4.34
4.00
2.63
4.90
5.01
5.13
4.94
4.81
4.67
4.34
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
53.53%
54.71%
56.12%
56.10%
56.13%
55.76%
55.11%
55.21%
55.32%
55.49%
55.23%
54.91%
Operating Profit Margin TTM
26.26%
28.42%
29.21%
29.88%
30.04%
29.60%
29.56%
29.30%
29.58%
30.43%
-1.83%
-1.81%
Net Profit Margin TTM
15.57%
17.48%
16.90%
18.09%
19.02%
18.86%
19.13%
18.54%
18.43%
18.60%
-7.11%
-7.26%
Growth Metrics
Net Revenue Growth (1Y)
-1.36%
-4.31%
-1.31%
-0.02%
0.63%
1.10%
-1.41%
-1.45%
-1.49%
-0.21%
2.29%
1.74%
Net Income Growth (1Y)
-19.24%
-11.32%
-12.82%
-2.48%
3.84%
2.52%
-365.19%
-351.88%
-343.33%
-354.34%
-138.35%
-139.20%
EPS Growth (1Y)
-15.82%
-9.05%
-9.70%
-1.23%
4.70%
2.64%
-365.96%
-352.05%
-342.75%
-355.02%
-138.32%
-139.29%
Valuation Metrics
P/E TTM
13.04
15.09
15.84
15.23
18.55
19.91
18.10
17.38
16.74
17.25
-37.75
-34.75
P/B TTM
1.17
1.52
1.61
1.68
2.13
2.33
2.17
2.07
2.04
2.18
1.90
1.85
P/S TTM
2.03
2.64
2.68
2.75
3.53
3.76
3.46
3.22
3.09
3.21
2.68
2.52
Market Cap
2.24B
2.87B
2.95B
3.06B
3.95B
4.27B
3.87B
3.58B
3.43B
3.61B
3.05B
2.84B
Enterprise Value
2.15B
3.80B
3.92B
3.93B
4.80B
5.17B
4.81B
4.58B
4.49B
4.69B
4.18B
4.04B
Calculated Values
Free Cash Flow TTM
313.53M
186.86M
207.60M
195.87M
130.08M
243.29M
248.69M
254.64M
246.39M
239.38M
232.04M
215.70M
Net Debt
-89.13M
930.09M
971.17M
874.04M
853.25M
894.47M
941.10M
1.00B
1.06B
1.08B
1.14B
1.20B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-11Sale
Owner: Zerillo, Jeffrey
Title: Senior VP Operations
Shares: 351
Price/Share: $52.28
Value: $18,350.28
Shares Owned: 41,810
Relationship: Officer
Ownership: Direct
2026-05-07Sale
Owner: Zerillo, Jeffrey
Title: Senior VP Operations
Shares: 305
Price/Share: $54.36
Value: $16,579.80
Shares Owned: 42,161
Relationship: Officer
Ownership: Direct
2026-05-05Sale
Owner: Zerillo, Jeffrey
Title: Senior VP Operations
Shares: 1,207
Price/Share: $54.99
Value: $66,372.93
Shares Owned: 42,820
Relationship: Officer
Ownership: Direct
2026-02-11Sale
Owner: Zerillo, Jeffrey
Title: Senior VP Operations
Shares: 1,000
Price/Share: $65.93
Value: $65,930.00
Shares Owned: 41,048
Relationship: Officer
Ownership: Direct
2025-12-01Sale
Owner: Zerillo, Jeffrey
Title: Senior VP Operations
Shares: 281
Price/Share: $60.00
Value: $16,860.00
Shares Owned: 42,048
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
103.71%
Inst. Shares: 50,254,095
Shares Outstanding: 48,456,000
2025-12-31
104.45%
Inst. Shares: 50,011,883
Shares Outstanding: 47,880,000
2025-09-30
100.29%
Inst. Shares: 49,168,933
Shares Outstanding: 49,025,000
2025-06-30
101.20%
Inst. Shares: 50,068,974
Shares Outstanding: 49,475,000
2025-03-31
99.68%
Inst. Shares: 49,535,599
Shares Outstanding: 49,697,000

Prestige Consumer Healthcare Inc. (PBH) — SEC Financial Statements & Analysis

Prestige Consumer Healthcare Inc. (PBH) is a pharmaceutical preparations company. Prestige Consumer Healthcare Inc. trades on NYSE as: PBH. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Prestige Consumer Healthcare Inc. reported a -1.36% year-over-year revenue growth, a Gross Profit Margin of 53.53% (TTM), a Debt-to-Equity ratio of 1.38x, a Price-to-Sales (P/S) ratio of 2.03x (TTM), a Price-to-Book (P/B) ratio of 1.17x (TTM), at a market cap of $2.24B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-1.36%
Gross Profit Margin TTM
53.53%
Debt To Equity
1.38x
P/S TTM
2.03x
P/B TTM
1.17x
Market Cap
$2.24B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Prestige Consumer Healthcare Inc. in?

Prestige Consumer Healthcare Inc. (PBH) operates in the Pharmaceutical Preparations industry.

What is PBH's market cap?

Prestige Consumer Healthcare Inc. (PBH) has a market capitalization of $2.24B as of 2026-06-30.

What is PBH's P/E ratio?

Prestige Consumer Healthcare Inc. (PBH)'s trailing twelve month P/E ratio is 13.04x as of 2026-06-30.

What exchange does PBH trade on?

Prestige Consumer Healthcare Inc. (PBH) trades on the NYSE.

Wall Street's data.
Main Street's price.